Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-023301
Filing Date
2025-02-19
Accepted
2025-02-19 16:55:23
Documents
67
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mnov-20241231.htm   iXBRL 10-K 2157348
2 EX-19.1 mnov-ex19_1.htm EX-19.1 259839
3 EX-23.1 mnov-ex23_1.htm EX-23.1 4437
4 EX-31.1 mnov-ex31_1.htm EX-31.1 12542
5 EX-31.2 mnov-ex31_2.htm EX-31.2 12467
6 EX-32.1 mnov-ex32_1.htm EX-32.1 10161
7 EX-32.2 mnov-ex32_2.htm EX-32.2 10511
  Complete submission text file 0000950170-25-023301.txt   8451958

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnov-20241231.xsd EX-101.SCH 987879
70 EXTRACTED XBRL INSTANCE DOCUMENT mnov-20241231_htm.xml XML 1416456
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33185 | Film No.: 25641314
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)